Long term cardiovascular consequences of chronic lung disease of prematurity

Chuen Yeow Poon1, Martin Oliver Edwards, Sailesh Kotecha

  • 1Department of Child Health, School of Medicine, Cardiff University, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK.

Insights

Preterm infants with chronic lung disease (CLD) may develop pulmonary hypertension and long-term systemic blood pressure issues. Their pulmonary vasculature remains sensitive to hypoxia into early childhood.

Area of Science:

  • Pediatric Cardiology
  • Neonatology
  • Pulmonary Medicine

Background:

  • Chronic lung disease of prematurity (CLD) is linked to pulmonary arterial (PA) hypertension in infants.
  • Impaired alveolar development and angiogenesis contribute to PA hypertension in CLD.
  • Children with CLD exhibit persistent pulmonary vascular hyper-reactivity to hypoxia.

Purpose of the Study:

  • To review the long-term effects of CLD on pulmonary and systemic circulations.
  • To explore clinical correlates and therapeutic strategies for CLD-related vascular changes.
  • To investigate potential increases in arterial stiffness in CLD survivors.

Main Methods:

  • Literature review of studies on preterm infants with CLD.
  • Analysis of data on pulmonary artery pressure and resistance.
  • Examination of systemic blood pressure and arterial stiffness in CLD survivors.

Main Results:

  • PA hypertension in preterm infants with CLD often resolves by school age.
  • Pulmonary vasculature remains hyper-reactive to hypoxia until early childhood.
  • Preterm children, with or without CLD, show mildly increased systemic blood pressure and arterial stiffness.

Conclusions:

  • CLD survivors may experience long-term alterations in both pulmonary and systemic circulations.
  • Increased smooth muscle tone, rather than reduced elasticity, may contribute to arterial stiffness.
  • Understanding these long-term effects is crucial for clinical management and therapeutic development.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
155